Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2011-06-22

Clinical Trial Update: Control of Helicobacter Pylori Infection by Dietary Supplementation With Lactobacillus Reuteri [NA]

View source ↗

Summary

A clinical trial exploring whether Lactobacillus reuteri dietary supplementation can control Helicobacter pylori infection and related dyspepsia; status is unkn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lactobacillus reuteri (Lactobacillus reuteri)

Snippet

Sponsor: Centro Regional para el Estudio de las Enfermedades Digestivas | Conditions: Helicobacter Pylori Infection, Dyspepsia | NA | Status: UNKNOWN